|
Volumn 15, Issue 4, 2017, Pages e80-e81
|
Nivolumab-Induced Colitis Treated by Infliximab
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
INFLIXIMAB;
METHYLPREDNISOLONE;
NIVOLUMAB;
PREDNISOLONE;
GASTROINTESTINAL AGENT;
IMMUNOLOGIC FACTOR;
IMMUNOLOGICAL ANTINEOPLASTIC AGENT;
ABDOMINAL PAIN;
ADULT;
APOPTOSIS;
ARTICLE;
BLOODY DIARRHEA;
CANCER IMMUNOTHERAPY;
CANCER RECURRENCE;
CASE REPORT;
COLITIS;
COLON BIOPSY;
COLONOSCOPY;
COMPUTER ASSISTED TOMOGRAPHY;
DRUG INFUSION;
DRUG TREATMENT FAILURE;
DRUG WITHDRAWAL;
ENUCLEATION;
FOLLOW UP;
HEALING;
HUMAN;
HUMAN TISSUE;
INFLAMMATORY INFILTRATE;
LABORATORY TEST;
LIVER METASTASIS;
MALE;
METASTASIS;
MIDDLE AGED;
RECTUM BIOPSY;
SIGMOIDOSCOPY;
STOMACH CANCER;
STOMACH METASTASIS;
TREATMENT DURATION;
UVEA MELANOMA;
CHEMICALLY INDUCED;
CYTOCHEMISTRY;
MICROSCOPY;
PATHOLOGY;
TREATMENT OUTCOME;
ANTINEOPLASTIC AGENTS, IMMUNOLOGICAL;
COLITIS;
COLONOSCOPY;
GASTROINTESTINAL AGENTS;
HISTOCYTOCHEMISTRY;
HUMANS;
IMMUNOLOGIC FACTORS;
INFLIXIMAB;
MALE;
MICROSCOPY;
MIDDLE AGED;
NIVOLUMAB;
TREATMENT OUTCOME;
|
EID: 85008205589
PISSN: 15423565
EISSN: 15427714
Source Type: Journal
DOI: 10.1016/j.cgh.2016.09.017 Document Type: Article |
Times cited : (56)
|
References (5)
|